article thumbnail

President Biden Signs End-of-Year Legislation Including Telehealth, Medicare & Medicaid, Mental Health, Pandemic Preparedness, and Other Health Care Provisions

C&M Health Law

trillion spending package, which consists of all 12 fiscal year (FY) 2023 appropriations bills and funds the federal government through September 30, 2023, provides additional assistance to Ukraine, and makes numerous health care policy changes. Agencies Funding Levels/Description Advanced Research Projects Agency for Health (ARPA-H) $1.5

Medicaid 104
article thumbnail

HHS Issues Final Rule Modifying the Confidentiality of Substance Use Disorder (SUD) Patient Records Regulations

HIPAA Journal

The bipartisan Coronavirus Aid, Relief, and Economic Security Act (CARES Act) called for the Part 2 regulations to be more closely aligned with the Health Insurance Portability and Accountability Act (HIPAA) Privacy, Breach Notification, and Enforcement Rules.

HIPAA 56
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Proposed Changes to the Confidentiality of Substance Use Disorder Patient Records Regulations

Hall Render

On December 2, 2022, the Department of Health and Human Services (“HHS”) Substance Abuse and Mental Health Services Administration (“SAMHSA”) released a proposed rule modifying the Confidentiality of Substance Use Disorder Patient Records regulations at 42 CFR Part 2 (“Part 2”).

HIPAA 75
article thumbnail

HHS Proposes Significant Amendments to Part 2 Regulations Governing the Confidentiality of Substance Use Disorder Records

C&M Health Law

Attorney and the Substance Abuse and Mental Health Services Administration. Specifically, in the event of a breach of unsecured Part 2 records, Part 2 programs would be required to notify HHS, affected patients, and, in some cases, media outlets. While HHS considered an opt-in approach to de-identification (i.e.,

article thumbnail

The Wait is Over. Or Is It? DEA’s Proposed Rules Around Telemedicine Prescribing: Initial Impressions and Key Takeaways

Health Law Advisor

Presently, all practitioners who have a current DEA registration that includes Schedule III authority may prescribe buprenorphine for Opioid Use Disorder in their practice if permitted by applicable state law and the federal Substance Abuse and Mental Health Services Administration (“SAMHSA”) encourages them to do so.

article thumbnail

Key Healthcare Provisions of the Consolidated Appropriations Act, 2023

Healthcare Law Blog

The high level summary below of some of the Act’s more notable components that are significant in the healthcare arena is not meant to be an exhaustive list of all health policy changes or provisions included in the Act. The Act extends certain flexibilities for Medicare coverage and payment for telehealth services through December 31, 2024.